CORC  > 武汉大学
A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-beta 1-Induced EMT in Vivo and in Vitro
Liu, Jian-Hua; He, Long; Zou, Zhi-Miao; Ding, Zuo-Chuan; Zhang, Xue; Wang, Hao; Zhou, Ping; Xie, Lin; Yi, Cheng-Zhi; Xing, Shuai
刊名KIDNEY & BLOOD PRESSURE RESEARCH
2018
卷号43期号:5
关键词MyD88 Epithelial-mesenchymal transition Renal interstitial fibrosis NF-kappa B Transforming growth factor beta 1
ISSN号1420-4096
DOI10.1159/000494745
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4230445
专题武汉大学
推荐引用方式
GB/T 7714
Liu, Jian-Hua,He, Long,Zou, Zhi-Miao,et al. A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-beta 1-Induced EMT in Vivo and in Vitro[J]. KIDNEY & BLOOD PRESSURE RESEARCH,2018,43(5).
APA Liu, Jian-Hua.,He, Long.,Zou, Zhi-Miao.,Ding, Zuo-Chuan.,Zhang, Xue.,...&Xing, Shuai.(2018).A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-beta 1-Induced EMT in Vivo and in Vitro.KIDNEY & BLOOD PRESSURE RESEARCH,43(5).
MLA Liu, Jian-Hua,et al."A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-beta 1-Induced EMT in Vivo and in Vitro".KIDNEY & BLOOD PRESSURE RESEARCH 43.5(2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace